Abstract:Gynostemma pentaphyllum (Thunb.) Makino (G. pentaphyllum) is a natural herbal drug that has been widely used to treat many diseases. The antitumor effects of G. pentaphyllum were first described in the illustrated catalog of plants. Gypenosides are the major active components of G. pentaphyllum, and they have been widely reported to possess antitumor effects in prostate cancer, gastric cancer, hepatocellular carcinoma, colon cancer, lung cancer, and breast cancer. However, research on the use of gypenoside in the treatment of bladder cancer has not been conducted. In this study, we explored the potential molecular mechanisms of gypenosides in the treatment of bladder cancer using network pharmacology and experimental validation. First, we used a network pharmacology–based method to identify both the effective components of gypenosides and the molecular mechanism underlying their antibladder cancer effects. The results were further confirmed by molecular docking, CCK8 and colony formation assays, and cell cycle and cell apoptosis analyses. Additionally, a mouse xenograft model of bladder cancer was used to investigate the antitumor effect of gypenosides in vivo. We identified 10 bioactive ingredients and 163 gene targets of gypenosides. Network exploration suggested that VEGFA, STAT3, and PI3KCA may be candidate agents for the antibladder cancer effect of gypenosides. In addition, analysis of the Kyoto Encyclopedia of Genes and Genomes pathway revealed that the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway may play a crucial role in the mechanism of action of gypenosides against bladder cancer. Molecular docking revealed that gypenosides combine well with PI3K, AKT, and mTOR. As expected, gypenosides displayed apoptosis-inducing properties in bladder cancer cells by inactivating the PI3K/AKT/mTOR signaling pathway in vitro. Furthermore, gypenosides significantly ( P < 0.05 ) inhibited the growth of bladder cancer cells in vivo. Mechanistically, gypenosides induced the apoptosis of bladder cancer cells via inactivation of the PI3K/AKT/mTOR signaling pathway.

Anti-cancer Effect and the Underlying Mechanisms of Gypenosides on Human Colorectal Cancer SW-480 Cells.

Antiproliferation and Anti-Migration Induced by Gypenosides in Human Colon Cancer SW620 and Esophageal Cancer Eca-109 Cells

Gypenosides Induce Cell Death and Alter Gene Expression in Human Oral Cancer HSC-3 Cells

Gypenosides Induced Apoptosis in Human Colon Cancer Cells Through the Mitochondria-Dependent Pathways and Activation of Caspase-3.

Gypenosides Suppress Growth of Human Oral Cancer SAS Cells In Vitro and in a Murine Xenograft Model

Gypenosides induced G0/G1 arrest via CHk2 and apoptosis through endoplasmic reticulum stress and mitochondria-dependent pathways in human tongue cancer SCC-4 cells.

An Experimental Study on the Antileukemia Effects of Gypenosides in Vitro and in Vivo

Gypenosides Causes DNA Damage and Inhibits Expression of DNA Repair Genes of Human Oral Cancer SAS Cells.

Gypenosides Inhibits Migration and Invasion of Human Oral Cancer SAS Cells Through the Inhibition of Matrix Metalloproteinase-2 -9 and Urokinase-Plasminogen by ERK1/2 and NF-kappa B Signaling Pathways.

Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation

Gypenosides Induced G0/G1 Arrest Via Inhibition of Cyclin E and Induction of Apoptosis Via Activation of Caspases-3 and -9 in Human Lung Cancer A-549 Cells.

Gypenoside induces apoptosis by inhibiting the PI3K/AKT/mTOR pathway and enhances T-cell antitumor immunity by inhibiting PD-L1 in gastric cancer

Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9.

Uncovering the Anti-Nsclc Effects and Mechanisms of Gypenosides by Metabolomics and Network Pharmacology Analysis.

2-(Pro-1-ynyl)-5-(5,6-dihydroxypenta-1,3-diynyl) thiophene induces apoptosis through reactive oxygen species-mediated JNK activation in human colon cancer SW620 cells.

Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer

Gypenoside L Inhibits Autophagic Flux and Induces Cell Death in Human Esophageal Cancer Cells Through Endoplasm Reticulum Stress-Mediated Ca2+ Release.

Gypenoside inhibits gastric cancer proliferation by suppressing glycolysis via the Hippo pathway

Molecular evidence of anti-leukemia activity of gypenosides on human myeloid leukemia HL-60 cells in vitro and in vivo using a HL-60 cells murine xenograft model

Gypensapogenin I Suppresses Cell Proliferation in Triple-Negative Breast Cancer Via Triggering the Closure of AKT/GSK3β/β-Catenin and Notch-1 Signaling Pathways

Gypenoside L, Isolated from Gynostemma Pentaphyllum, Induces Cytoplasmic Vacuolation Death in Hepatocellular Carcinoma Cells Through Reactive-Oxygen-Species-Mediated Unfolded Protein Response